AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial – study protocol

Autor: Tara T. M. Lee, Corinne Collett, Mei-See Man, Matt Hammond, Lee Shepstone, Sara Hartnell, Eleanor Gurnell, Caroline Byrne, Eleanor M. Scott, Robert S. Lindsay, Damian Morris, Anna Brackenridge, Anna R. Dover, Rebecca M. Reynolds, Katharine F. Hunt, David R. McCance, Katharine Barnard-Kelly, David Rankin, Julia Lawton, Laura E. Bocchino, Judy Sibayan, Craig Kollman, Malgorzata E. Wilinska, Roman Hovorka, Helen R. Murphy, on behalf of the AiDAPT Collaborative Group

Publikováno v: BMC Pregnancy and Childbirth, Vol 22, Iss 1, Pp 1-10 (2022)

Abstract Background Pregnant women with type 1 diabetes strive for tight glucose targets (3.5-7.8 mmol/L) to minimise the risks of obstetric and neonatal complications. Despite using diabetes technologies including continuous glucose monitoring (CGM)

Externí odkaz: https://doaj.org/article/1040a294e4914043b9de266ca4e070a9

AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol

Autor: Lee, Tara TM, Collett, Corinne, Man, Mei-See, Hammond, Matt, Shepstone, Lee, Hartnell, Sara, Gurnell, Eleanor, Byrne, Caroline, Scott, Eleanor M, Lindsay, Robert S, Morris, Damian, Brackenridge, Anna, Dover, Anna R, Reynolds, Rebecca M, Hunt, Katharine F, McCance, David R, Barnard-Kelly, Katharine, Rankin, David, Lawton, Julia, Bocchino, Laura E, Sibayan, Judy, Kollman, Craig, Wilinska, Malgorzata E, Hovorka, Roman, Murphy, Helen R, AiDAPT Collaborative Group

Publikováno v: Lee, T, Collett, C, Man, M-S, Hammond, M, Shepstone, L, Hartnell, S, Gurnell, E, Byrne, C, Scott, E M, Lindsay, R, Morris, D, Brackenridge, A, Dover, A, Reynolds, R, Hunt, K, McCrance, D, Barnard-Kelly, K, Rankin, D, Lawton, J, Bocchino, L, Sibayan, J, Kollman, C, Wilinska, M E, Hovorka, R & Murphy, H R 2022, ' AiDAPT: Automated insulin Delivery Amongst Pregnant women with Type 1 diabetes : A multicentre randomized controlled trial – study protocol ', BMC pregnancy and childbirth, vol. 22, no. 1, 282 . https://doi.org/10.1186/s12884-022-04543-z

Background Pregnant women with type 1 diabetes strive for tight glucose targets (3.5-7.8 mmol/L) to minimise the risks of obstetric and neonatal complications. Despite using diabetes technologies including continuous glucose monitoring (CGM), insulin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be95ede108f8062b812aee1441771a60
https://www.repository.cam.ac.uk/handle/1810/336911